Siren Biotechnology

Risk score

57

Headquarters

Flag of United States of AmericaUnited States of America

Siren Biotechnology merges two revolutionary therapeutic methods – AAV gene therapy and cytokine immunotherapy – into an innovative approach that addresses major obstacles and transforms the way we eradicate tumor cells and stimulate anti-tumor response. At Siren, we have developed Universal AAV Immuno-Gene Therapy.